Appointments: New CEOs For Lundbeck, Voyager & Neos, CSOs For iTeos & Tilos
Executive Summary
Deborah Dunsire’s appointment to lead Lundbeck tops this week’s list of new hires; Astellas, Orchard Therapeutics, Voyager Therapeutics, iTeos Therapeutics, Cevec Pharmaceuticals, Sangamo Therapeutics, Cedilla Therapeutics, Tilos Therepautics and Neos Therapeutics have also appointed new executives and directors.
You may also be interested in...
Pipeline Watch: Eight Approvals As CTAD Dominates Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Banner Year For Novo Nordisk At The 18th Annual Scrip Awards
AstraZeneca and Moderna also shone as the pharma, biotech and allied industries came together in London on 30 November to celebrate a year of exceptional achievement at the 18th Annual Scrip Awards, hosted by the actor, comedian and presenter Stephen Mangan.
Executives On The Move: Aerie Pharmaceuticals, Valeo Pharma and More
Recent executive changes in the industry include C-suite changes at ADC Therapeutics and ImmunoGen. Meanwhile, new directors were appointed at Aerie Pharmaceuticals and Adagene.